Latest Neurology Stories
2.3 Million Americans are "Long-Distance Caregivers" for people with Alzheimer's; Costs for Long-Distance Caregivers are Almost Twice as High CHICAGO, March 19, 2013 /PRNewswire-USNewswire/ -- According to the Alzheimer's Association 2013 Alzheimer's Disease Facts & Figures report released today, one in three seniors dies with Alzheimer's or another dementia in the United States. The new report shows that while deaths from other major diseases, such as heart disease, HIV/AIDS...
SAN DIEGO, March 18, 2013 /PRNewswire-USNewswire/ -- The American Academy of Neurology (AAN), the world's largest association of neurologists who treat brain injuries such as concussion, has launched a new app called "Concussion QuickCheck", to help coaches, athletic trainers, parents and athletes quickly evaluate if someone may have a concussion and needs to see a licensed health care provider, such as a neurologist, who is specialized in concussion. The app, which is available...
MINNEAPOLIS, March 18, 2013 /PRNewswire-USNewswire/ -- With more than one million athletes now experiencing a concussion each year in the United States, the American Academy of Neurology (AAN) has released an evidence-based guideline for evaluating and managing athletes with concussion. This new guideline replaces the 1997 AAN guideline on the same topic. The new guideline is published in the March 18, 2013, online issue of Neurology(®), the medical journal of the American Academy of...
Tests to be unveiled at the American Academy of Neurology Annual Meeting in San Diego, March 16-23, 2013 WORCESTER, Mass. and MADISON, N.J., March 18, 2013 /PRNewswire/ -- Athena Diagnostics, a leader in neurological diagnostics, today announced the clinical availability of new genetic tests to aid the detection of several rare neurological disorders, including hereditary neuropathy, neuromuscular disease, epilepsy and certain movement disorders. The lab-developed tests are available...
Test to be unveiled at the American Academy of Neurology Annual Meeting in San Diego, March 16-23, 2013 MADISON, N.J. and WORCESTER, Mass., March 18, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the availability of the first clinical test panel for aiding the diagnosis of suspected dementia due to treatable forms of cognitive impairment. The test panel is believed to be the first commercial...
Pseudotumor cerebri condition marked by excessive pressure in skull, most common in obese, premenopausal women between the ages of 18 and 40 A team of interventional neuroradiologists and neurosurgeons at Johns Hopkins reports wide success with a new procedure to treat pseudotumor cerebri, a rare but potentially blinding condition marked by excessive pressure inside the skull, caused by a dangerous narrowing of a vein located at the base of the brain. The Johns Hopkins team's latest...
James Berry, M.D., M.P.H., 2013 Recipient WASHINGTON, March 13, 2013 /PRNewswire-USNewswire/ -- The ALS Association and the American Academy of Neurology (AAN) are pleased to announce that James Berry, M.D., M.P.H., from the Department of Neurology, Massachusetts General Hospital, Boston, Mass., is this year's recipient for the Richard Olney AAN/ALS Association Clinician Scientist Development Award, which is a part of The Association's research program TREAT ALS (Translational...
Dr. Ratan with Burke Medical Research Institute directs research on stroke, spinal cord injury, pain, Parkinson, and Alzheimer. Stamford, CT (PRWEB) March 12, 2013 Introducing Raj Ratan, M.D., PhD. for media interviews. Dr. Ratan is the Executive Director at Winifred Masterson Burke Medical Research Institute and Professor of Neurology and Neuroscience & Associate Dean, Weill Cornell Medical College. Topics for commentary/opinion from Dr. Ratan: Neurological Research, Reduction of...
SAN DIEGO, March 12, 2013 /PRNewswire-USNewswire/ -- A new drug may improve memory problems in people with moderate Alzheimer's disease, according to a phase IIa study released today that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013. The drug is called ORM-12741. The drug is the first to target a specific subtype of adrenergic receptors (alpha-2C) in the brain, which are believed to be involved in modulation of brain...
SAN DIEGO, March 12, 2013 /PRNewswire-USNewswire/ -- Brain imaging soon after mild traumatic brain injury (mTBI) or mild concussion can detect tiny lesions that may eventually provide a target for treating people with mTBI, according to a study released today and that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013. Studies of brain tissue once a person has died have shown that different types of lesions are associated...
Latest Neurology Reference Libraries
Stroke is a peer-reviewed medical journal published monthly by Lippincott Williams & Wilkins on behalf of the American Heart Association. As of May 2012, the current editor-in-chief is Marc Fisher (University of Massachusetts Medical School). Stroke covers research on cerebral circulation and related diseases, including clinical research on assessment of risk for stroke, diagnosis, prevention, and treatment, as well as rehabilitation. The audience base for Stroke includes neurologists,...
Herpes zoster (or zoster), is known as shingles or zona and is a viral disease characterized by painful skin rash with blisters in a limited area on one side of the body. Initial infection causes chickenpox. Once chickenpox is over the virus remains in the body and can cause shingles. It can become latent in the nerve cell bodies and sometimes in the dorsal root, cranial nerve, or autonomic ganglion. Years after initial infection, another breakout can cause a painful rash. The rash usually...
